Sarissa Capital Management LP is Director & 10% Owner at IRONWOOD PHARMACEUTICALS INC (IRWD). They have made 5 open-market trades across 3 companies since 2016, most recently 2025-06-13.
CIK 0001577524
5 open-market purchases totalling $19.2M since 2016, never a sale. Across 5 scored buys the stock is down 16.0% at ninety days, and 22.2 points behind the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 60% | 20% | 20% |
| Avg Move | +8.7% | -3.3% | -16.0% |
| Alpha | +7.6% | -6.9% | -22.2% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| INVA | BUY | 2023-06-15 | 2023-06-20 | $13.13 | $814K | -0.9% | -1.6% | -3.2% |
| INVA | BUY | 2023-05-17 | 2023-05-19 | $13.22 | $1.3M | -3.5% | -5.7% | -0.1% |
| IRWD | BUY | 2021-03-08 | 2021-03-10 | $10.42 | $3.1M | +6.6% | -5.7% | +6.0% |
| APRI | BUY | 2016-03-03 | 2016-03-07 | $0.88 | $11.7M | +2.7% | -45.8% | -59.1% |
| APRI | BUY | 2016-01-12 | 2016-01-14 | $0.88 | $2.3M | +38.8% | +42.5% | -23.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.